Paper62946
Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet, 1976. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association. Papers, record 62946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62946
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ethambutol | Major topic |
| Isoniazid | Major topic |
| Rifampin | Major topic |
| Streptomycin | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39993187 | Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39993187 | PubMed |
| 38414662 | Pyrazinoic acid, the active form of the anti-tuberculosis drug pyrazinamide, and aromatic carboxylic acid analogs are protonophores. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/38414662 | PubMed |
| 29866864 | Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29866864 | PubMed |
| 28333978 | Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey. | PLoS One | 2017 | https://conductscience.org/library/papers/28333978 | PubMed |
| 27208770 | Drug-Resistant Tuberculosis: Challenges and Progress. | Infect Dis Clin North Am | 2016 | https://conductscience.org/library/papers/27208770 | PubMed |
| 27184366 | The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity? | BMC Infect Dis | 2016 | https://conductscience.org/library/papers/27184366 | PubMed |
| 26574016 | Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/26574016 | PubMed |
| 25530919 | Mechanisms of Pyrazinamide Action and Resistance. | Microbiol Spectr | 2013 | https://conductscience.org/library/papers/25530919 | PubMed |
| 23640554 | Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. | Indian J Med Res | 2013 | https://conductscience.org/library/papers/23640554 | PubMed |
| 22664964 | Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22664964 | PubMed |
| 19753109 | Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. | PLoS Med | 2009 | https://conductscience.org/library/papers/19753109 | PubMed |
| 16555622 | Tuberculosis 2004: challenges and opportunities. | Trans Am Clin Climatol Assoc | 2005 | https://conductscience.org/library/papers/16555622 | PubMed |
| 8300251 | Short course intermittent chemotherapy in childhood tuberculosis. | Infection | 1993 | https://conductscience.org/library/papers/8300251 | PubMed |
| 7530627 | Current and potential treatment of tuberculosis. | Drugs | 1994 | https://conductscience.org/library/papers/7530627 | PubMed |
| 7382540 | Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis. | Lung | 1980 | https://conductscience.org/library/papers/7382540 | PubMed |
| 6884240 | The case for short-course chemotherapy of pulmonary tuberculosis. | Drugs | 1983 | https://conductscience.org/library/papers/6884240 | PubMed |
| 6767845 | Treatment of tuberculosis. The Mitchell lecture 1979. | J R Coll Physicians Lond | 1980 | https://conductscience.org/library/papers/6767845 | PubMed |
| 6749471 | Short-course therapy for tuberculosis. | Drugs | 1982 | https://conductscience.org/library/papers/6749471 | PubMed |
| 6404492 | New drugs in respiratory disorders. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6404492 | PubMed |
| 4030288 | Tuberculosis undefeated. | Ir J Med Sci | 1985 | https://conductscience.org/library/papers/4030288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/62946
GET https://conductscience.org/api/papers/v1/62946/cited_by?page=2